We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUS icon
1326
ePlus
PLUS
$2.32B
$1.18M 0.01%
15,995
+996
+7% +$87K
DRH icon
1327
Diamondrock Hospitality Co
DRH
$2.5B
$1.18M 0.01%
130,776
+8,806
+7% +$80.4K
SHC icon
1328
Sotera Health
SHC
$5.39B
$1.18M 0.01%
86,177
+7,174
+9% +$104K
KWR icon
1329
Quaker Houghton
KWR
$2.95B
$1.18M 0.01%
8,368
+295
+4% +$46.6K
BATRK icon
1330
Atlanta Braves Holdings Series B
BATRK
$3.41B
$1.17M 0.01%
30,668
+1,691
+6% +$67.4K
ALKT icon
1331
Alkami Technology
ALKT
$2.22B
$1.17M 0.01%
31,791
+6,285
+25% +$235K
ROG icon
1332
Rogers Corp
ROG
$2.48B
$1.17M 0.01%
11,471
+630
+6% +$65.7K
DYN icon
1333
Dyne Therapeutics
DYN
$4.85B
$1.17M 0.01%
49,467
+2,748
+6% +$81.3K
BEAM icon
1334
Beam Therapeutics
BEAM
$2.74B
$1.16M 0.01%
46,900
+3,366
+8% +$85.9K
HLMN icon
1335
Hillman Solutions
HLMN
$1.73B
$1.16M 0.01%
119,406
+2,391
+2% +$25.6K
ALG icon
1336
Alamo Group
ALG
$2.01B
$1.16M 0.01%
6,252
+343
+6% +$64.1K
AKRO
1337
DELISTED
Akero Therapeutics
AKRO
$1.16M 0.01%
41,565
+2,322
+6% +$70.3K
SKWD icon
1338
Skyward Specialty Insurance
SKWD
$2.44B
$1.15M 0.01%
22,841
+1,224
+6% +$59.4K
KMT icon
1339
Kennametal
KMT
$2.35B
$1.15M 0.01%
48,037
+2,763
+6% +$73.6K
LMAT icon
1340
LeMaitre Vascular
LMAT
$1.87B
$1.15M 0.01%
12,434
+695
+6% +$66.8K
LGIH icon
1341
LGI Homes
LGIH
$1.32B
$1.14M 0.01%
12,757
+701
+6% +$73.6K
WSBC icon
1342
WesBanco
WSBC
$4.07B
$1.14M 0.01%
35,043
+1,911
+6% +$63.3K
LMND icon
1343
Lemonade
LMND
$4.1B
$1.14M 0.01%
31,068
+1,391
+5% +$44.4K
CNXC icon
1344
Concentrix
CNXC
$1.5B
$1.14M 0.01%
26,313
+2,004
+8% +$89.1K
AGIO icon
1345
Agios Pharmaceuticals
AGIO
$2.04B
$1.14M 0.01%
34,579
+1,916
+6% +$90K
MBC icon
1346
MasterBrand
MBC
$1.87B
$1.14M 0.01%
77,696
+4,229
+6% +$72.1K
KYMR icon
1347
Kymera Therapeutics
KYMR
$9.51B
$1.13M 0.01%
28,211
+2,323
+9% +$105K
VERA icon
1348
Vera Therapeutics
VERA
$2.08B
$1.13M 0.01%
26,803
+4,025
+18% +$178K
GBX icon
1349
The Greenbrier Companies
GBX
$1.41B
$1.13M 0.01%
18,515
+1,320
+8% +$80.5K
LZB icon
1350
La-Z-Boy
LZB
$1.64B
$1.13M 0.01%
25,856
+1,231
+5% +$52K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.